Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

Pfizer showcases JAK pipeline with midstage results

$
0
0
The pharma will advance its JAK3 inhibitor in alopecia areata while focusing its TYK2JAK1 blocker on psoriasis Crohn&39;s and ulcerative colitis.

Viewing all articles
Browse latest Browse all 2985

Trending Articles